The waiting time for prostate cancer treatment in Italy: analysis from the Pros-IT CNR study.

摘要: Background Prostate cancer (PCa) is the second most common neoplasm in male patients. To date, there's no certain indication about maximum waiting time (WT) acceptable for treatment beginning and impact on oncological functional outcomes has not been well established. Methods Data from National Research Council PCa monitoring multicenter project Italy (Pros-IT CNR) were prospectively collected analyzed. WT was defined as bioptical diagnosis of to first received. Patients divided two groups, using a frame 90 days. Quality life measured through Italian version University California Los Angeles-Prostate Cancer Index (UCLA-PCI) Short-Form Health Survey (SF-12). The occurrence upgrading, upstaging, presence lymph node metastasis positive surgical margins at final histopathological diagnosis, PSA 12 months follow-up evaluated. Results overall median 93 logistic multivariable model confirmed that age, being resident Southern regions T staging significantly associated with >90 At 6 mean SF-12 score emotionalpsychological component lower ≥ days group (p=0.0428). Among patients treated approach, significant differences found groups. Conclusions In our study clinical stage provenance are > might have outcome.